News and Trends 4 Mar 2020
Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B
UK biotech Immunocore has raised €116.7M in Series B funding to develop drugs that harness the body’s immune cells to fight cancer, viral infections, and autoimmune diseases. This latest funding round for the company, which specializes in redirecting and activating T-cells, includes an international group of new investors led by the US private equity firm […]